Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Jul 6, 2019
Open Peer Review Period: Jul 8, 2019 - Jul 12, 2019
Date Accepted: Sep 23, 2019
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Reducing Potentially Inappropriate Prescriptions for Older Patients Using Computerized Decision Support Tools: Systematic Review

Monteiro L, Maricoto T, Solha I, Ribeiro-Vaz I, Martins C, Monteiro-Soares M

Reducing Potentially Inappropriate Prescriptions for Older Patients Using Computerized Decision Support Tools: Systematic Review

J Med Internet Res 2019;21(11):e15385

DOI: 10.2196/15385

PMID: 31724956

PMCID: 6883366

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Reducing potentially inappropriate prescriptions for older patients using computerized decision support tools- a systematic review

  • Luís Monteiro; 
  • Tiago Maricoto; 
  • Isabel Solha; 
  • Inês Ribeiro-Vaz; 
  • Carlos Martins; 
  • Matilde Monteiro-Soares

ABSTRACT

Background:

Older adults are more vulnerable to polypharmacy, in addition to prescriptions of potentially inappropriate medications. There are several ways to address polypharmacy to prevent its occurrence. We focused on computerized decision support tools

Objective:

We reviewed the available literature to understand whether computerized decision support (CDS) tools reduce potentially inappropriate prescriptions (PIP) or medications (PIM) in older adult patients and impact health outcomes.

Methods:

We conducted a systematic review by searching literature in the MEDLINE, CENTRAL, EMBASE, and Web of Science databases for interventional studies published through February 2018 to assess the impact of CDS tools on PIM/PIP in people age ≥ 65 years.

Results:

A total of 3,756 articles were identified, and 15 were included. More than half (n=9) of the studies were randomized controlled trials (RCTs), 7% (n=1) were cross-over studies, and 33% (n=5) were before and after studies. A total of 232,872 participants were included and assessed in RCTs (mean: 25,875; range: 196-72072). Intervention designs had several different features. CDS tools consistently reduced the number of PIP started and mean number of PIP per patient. CDS tools also increased PIP discontinuation and drug appropriateness. However, in several studies, statistical significance was not achieved. A meta-analysis was not possible due to the significant heterogeneity among the systems used and the definitions of outcomes.

Conclusions:

CDS tools may reduce PIP/PIM. More RCTs assessing the impact of CDS tools that could be used both in primary health care (PHC) and secondary health care (SHC) are needed to evaluate the use of medication targets defined by Beers or STOPP criteria, adverse drug reactions, quality of life measurements, and patient and professional satisfaction with a reasonable follow-up, which could clarify the clinical usefulness of these tools


 Citation

Please cite as:

Monteiro L, Maricoto T, Solha I, Ribeiro-Vaz I, Martins C, Monteiro-Soares M

Reducing Potentially Inappropriate Prescriptions for Older Patients Using Computerized Decision Support Tools: Systematic Review

J Med Internet Res 2019;21(11):e15385

DOI: 10.2196/15385

PMID: 31724956

PMCID: 6883366

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.